Literature DB >> 20833942

Japanese version of the Delirium Rating Scale, Revised-98 (DRS-R98-J): reliability and validity.

Masashi Kato1, Yasuhiro Kishi, Toru Okuyama, Paula T Trzepacz, Takashi Hosaka.   

Abstract

BACKGROUND: Delirium is a common neuropsychiatric disorder in medical and surgical inpatients of all ages. It is associated with increased long-term mortality, longer length of hospital stay, poor functional recovery, and increased likelihood of nursing home placement.
OBJECTIVE: The aim of this study was to investigate the reliability and the validity of the Japanese translation of the Delirium Rating Scale, Revised-98 (DRS-R-98).
METHOD: Psychiatric-consultation patients were assessed to compare groups of delirium, dementia, and non-delirium.
RESULTS: Mean Total and Severity scores significantly distinguished delirium from the other groups. The scale had high interrater reliability and high internal consistency. Mean Severity scores during delirium differed from the posttreatment scores. Stratum-specific likelihood ratios showed that the DRS-R98-J is a reliable diagnostic tool.
CONCLUSION: This study indicates that the Japanese version of the DRS-R-98 has high reliability and validity, and is a useful tool for assessing delirium among Japanese medically ill populations.

Entities:  

Mesh:

Year:  2010        PMID: 20833942     DOI: 10.1176/appi.psy.51.5.425

Source DB:  PubMed          Journal:  Psychosomatics        ISSN: 0033-3182            Impact factor:   2.386


  6 in total

1.  Current Pharmacotherapy Does Not Improve Severity of Hypoactive Delirium in Patients with Advanced Cancer: Pharmacological Audit Study of Safety and Efficacy in Real World (Phase-R).

Authors:  Toru Okuyama; Kazuhiro Yoshiuchi; Asao Ogawa; Satoru Iwase; Naosuke Yokomichi; Akihiro Sakashita; Keita Tagami; Keiichi Uemura; Rika Nakahara; Tatsuo Akechi
Journal:  Oncologist       Date:  2019-01-04

2.  Korean version of the delirium rating scale-revised-98: reliability and validity.

Authors:  Yanghyun Lee; Jian Ryu; Jinyoung Lee; Hwi-Jung Kim; Im Hee Shin; Jeong-Lan Kim; Paula T Trzepacz
Journal:  Psychiatry Investig       Date:  2010-12-13       Impact factor: 2.505

3.  Yokukansan for perioperative psychiatric symptoms in cancer patients undergoing high invasive surgery. J-SUPPORT 1605 (ProD Study): study protocol for a randomized controlled trial.

Authors:  Saho Wada; Ryoichi Sadahiro; Yutaka J Matsuoka; Yosuke Uchitomi; Takuhiro Yamaguchi; Ken Shimizu
Journal:  Trials       Date:  2019-02-08       Impact factor: 2.279

4.  Reversibility of delirium in Ill-hospitalized cancer patients: Does underlying etiology matter?

Authors:  Yoshinobu Matsuda; Isseki Maeda; Tatsuya Morita; Toshihiro Yamauchi; Akihiro Sakashita; Hiroaki Watanabe; Keisuke Kaneishi; Koji Amano; Satoru Iwase; Asao Ogawa; Kazuhiro Yoshiuchi
Journal:  Cancer Med       Date:  2019-11-06       Impact factor: 4.452

5.  Delirium diagnosis defined by cluster analysis of symptoms versus diagnosis by DSM and ICD criteria: diagnostic accuracy study.

Authors:  Esteban Sepulveda; José G Franco; Paula T Trzepacz; Ana M Gaviria; David J Meagher; José Palma; Eva Viñuelas; Imma Grau; Elisabet Vilella; Joan de Pablo
Journal:  BMC Psychiatry       Date:  2016-05-26       Impact factor: 3.630

6.  JPOS/JASCC clinical guidelines for delirium in adult cancer patients: a summary of recommendation statements.

Authors:  Yoshinobu Matsuda; Hitoshi Tanimukai; Shinichiro Inoue; Shuji Inada; Koji Sugano; Hideaki Hasuo; Masafumi Yoshimura; Saho Wada; Chikako Dotani; Hiroyoshi Adachi; Yoshiaki Okamoto; Mari Takeuchi; Daisuke Fujisawa; Jun Kako; Chiyuki Sasaki; Yasuhiro Kishi; Nobuya Akizuki; Masatoshi Inagaki; Yosuke Uchitomi; Eisuke Matsushima; Toru Okuyama
Journal:  Jpn J Clin Oncol       Date:  2020-05-05       Impact factor: 3.019

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.